In a March 10 earnings call, executive chairman of Surgery Partners, Inc., a fast-growing company offering surgical services via more than 180 ambulatory surgery centers (ASCs) in 30 states, Wayne DeVeydt said musculoskeletal surgery in ASCs is “exploding,” and with medicare’s approval to reimburse ASCs for percutaneous coronary interventions (PCI), the cardio space is their next target for growth. We a look at the outlook on cardio ASC growth, its opportunities and its challenges for physicians, and what it means for quality PCI outcomes.
“Specifically, we estimate that there is over $60 billion of cases that will shift from inpatient to outpatient over the next several years,” said Evans in prepared statements. “And, we estimate that over 60% of those procedures are in musculoskeletal and cardiology.”